Concepedia

Heather G. Jørgensen

HG

Statistics

Publications

34

Citations

3.6K

H-Index

26

Active since

2001

Affiliations

University of Glasgow(Current)

Blood Cancer UK

University of Strathclyde

BC Cancer Agency

Gartnavel General Hospital

Heather G. Jørgensen is an author at University of Glasgow specializing in life sciences, oncology, and chronic myeloid leukemia therapy.

ORCID

Publications per year

2001–2024

34

Publications

34

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

Susan M. Graham, Heather G. Jørgensen, Elaine Allan et al. · Blood · 2002 · 1.2K citations · Full text

, , +13

Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cells

Heather G. Jørgensen, Elaine Allan, Niove E. Jordanides et al. · Blood · 2007 · 303 citations · Full text

, , +4

Functional ABCG2 is overexpressed on primary CML CD34+ cells and is inhibited by imatinib mesylate

Niove E. Jordanides, Heather G. Jørgensen, Tessa L. Holyoake et al. · Blood · 2006 · 158 citations · Full text

, , +7

JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo

Paolo Gallipoli, Amy Cook, Susan Rhodes et al. · Blood · 2014 · 155 citations · Full text

, , +10

Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3

Tessa L. Holyoake, Xiaoyan Jiang, Heather G. Jørgensen et al. · Blood · 2001 · 150 citations · Full text

, , +8

1–5 of 34